Stimulation of cholesterol biosynthesis in mitochondrial complex I-deficiency lowers reductive stress and improves motor function and survival in mice.

[1]  C. Thompson,et al.  Proline biosynthesis is a vent for TGFβ‐induced mitochondrial redox stress , 2020, The EMBO journal.

[2]  Robert W. Taylor,et al.  Metabolic effects of bezafibrate in mitochondrial disease , 2020, EMBO molecular medicine.

[3]  J. Smeitink,et al.  Effects of clofibrate and KH176 on life span and motor function in mitochondrial complex I-deficient mice. , 2020, Biochimica et biophysica acta. Molecular basis of disease.

[4]  Chenqi Xu,et al.  Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities , 2020, Nature Metabolism.

[5]  Russell P. Goodman,et al.  An engineered enzyme that targets circulating lactate to alleviate intracellular NADH/NAD+ imbalance , 2019, Nature Biotechnology.

[6]  C. V. von Arnim,et al.  NADH Autofluorescence—A Marker on its Way to Boost Bioenergetic Research , 2018, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[7]  C. Bisgaier,et al.  Comparative Evaluation of Gemcabene and Peroxisome Proliferator–Activated Receptor Ligands in Transcriptional Assays of Peroxisome Proliferator–Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease , 2018, Journal of cardiovascular pharmacology.

[8]  A. Heerschap,et al.  Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease , 2017, Scientific Reports.

[9]  V. Mootha,et al.  A genetically encoded tool for manipulation of NADP+/NADPH in living cells , 2017, Nature chemical biology.

[10]  M. Jansen,et al.  Assisted 6‐minute cycling test: An exploratory study in children , 2016, Muscle & nerve.

[11]  V. Mootha,et al.  Complementation of mitochondrial electron transport chain by manipulation of the NAD+/NADH ratio , 2016, Science.

[12]  M. García de Bravo,et al.  Inhibition of Mevalonate Pathway and Synthesis of the Storage Lipids in Human Liver-Derived and Non-liver Cell Lines by Lippia alba Essential Oils , 2016, Lipids.

[13]  P. Willems,et al.  Complex I and complex III inhibition specifically increase cytosolic hydrogen peroxide levels without inducing oxidative stress in HEK293 cells , 2015, Redox biology.

[14]  R. Rodenburg,et al.  Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition. , 2015, Cell metabolism.

[15]  J. Boyer,et al.  Fibrates and cholestasis , 2015, Hepatology.

[16]  M. Rutkowska,et al.  Fenofibrate subcellular distribution as a rationale for the intracranial delivery through biodegradable carrier. , 2015, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[17]  Wen Huang,et al.  Robinetinidol-flavone attenuates cholesterol synthesis in hepatoma cells via inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. , 2015, Molecular medicine reports.

[18]  S. Rahman,et al.  Development of pharmacological strategies for mitochondrial disorders , 2014, British journal of pharmacology.

[19]  Matt Kaeberlein,et al.  mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome , 2013, Science.

[20]  Matthew G. Vander Heiden,et al.  Metabolic targets for cancer therapy , 2013, Nature Reviews Drug Discovery.

[21]  M. Breitenbach,et al.  Loss of cytochrome c oxidase promotes RAS-dependent ROS production from the ER resident NADPH oxidase, Yno1p, in yeast. , 2013, Cell metabolism.

[22]  S. Rahman,et al.  189th ENMC International workshop Complex I deficiency: Diagnosis and treatment 20–22 April 2012, Naarden, The Netherlands , 2013, Neuromuscular Disorders.

[23]  Martijn A. Huynen,et al.  Inferring Metabolic States in Uncharacterized Environments Using Gene-Expression Measurements , 2013, PLoS Comput. Biol..

[24]  T. Moliné,et al.  Oxidative stress and cancer: An overview , 2013, Ageing Research Reviews.

[25]  S. Wortmann,et al.  Developing outcome measures for pediatric mitochondrial disorders: which complaints and limitations are most burdensome to patients and their parents? , 2013, Mitochondrion (Amsterdam. Print).

[26]  G. Herman,et al.  Disorders of sterol synthesis: Beyond Smith–Lemli–Opitz syndrome , 2012, American journal of medical genetics. Part C, Seminars in medical genetics.

[27]  G. Porter,et al.  Mitochondria as a Drug Target in Ischemic Heart Disease and Cardiomyopathy , 2012, Circulation research.

[28]  R. Rodenburg,et al.  Metabolic consequences of NDUFS4 gene deletion in immortalized mouse embryonic fibroblasts. , 2012, Biochimica et biophysica acta.

[29]  Leen Stougie,et al.  Optimal flux spaces of genome-scale stoichiometric models are determined by a few subnetworks , 2012, Scientific Reports.

[30]  A. Voets,et al.  Transcriptional changes in OXPHOS complex I deficiency are related to anti-oxidant pathways and could explain the disturbed calcium homeostasis. , 2012, Biochimica et biophysica acta.

[31]  Werner J H Koopman,et al.  Monogenic mitochondrial disorders. , 2012, The New England journal of medicine.

[32]  M. Beal,et al.  Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease. , 2012, Human molecular genetics.

[33]  A. Suomalainen,et al.  Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice. , 2012, Human molecular genetics.

[34]  Petra C. Kienesberger,et al.  ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1 , 2011, Nature Medicine.

[35]  E. Schon,et al.  In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis , 2011, Cell metabolism.

[36]  R. Simó,et al.  Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo. , 2011, Biochimica et biophysica acta.

[37]  R. Palmiter,et al.  Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome , 2010, Proceedings of the National Academy of Sciences.

[38]  R. Rodenburg.  Biochemical diagnosis of mitochondrial disorders , 2010, Journal of Inherited Metabolic Disease.

[39]  J. VanderGheynst,et al.  Rapid Quantitative Analysis of Lipids Using a Colorimetric Method in a Microplate Format , 2010, Lipids.

[40]  S. Srivastava,et al.  PGC-1alpha/beta induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders. , 2009, Human molecular genetics.

[41]  R. Rodenburg,et al.  Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. , 2008, Brain : a journal of neurology.

[42]  R. Margreiter,et al.  Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells , 2008, Nature Protocols.

[43]  W. Watt,et al.  Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy. , 2008, Cell metabolism.

[44]  A. Munnich,et al.  Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. , 2008, The Journal of clinical endocrinology and metabolism.

[45]  J. Smeitink,et al.  Life cell quantification of mitochondrial membrane potential at the single organelle level , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[46]  J. Smeitink,et al.  Mitochondrial and cytosolic thiol redox state are not detectably altered in isolated human NADH:ubiquinone oxidoreductase deficiency. , 2007, Biochimica et biophysica acta.

[47]  You-Sun Kim,et al.  TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. , 2007, Molecular cell.

[48]  Monica L. Mo,et al.  Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.

[49]  Anne E Carpenter,et al.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.

[50]  A. Tall,et al.  Retinoic Acid Receptor-Mediated Induction of ABCA1 in Macrophages , 2003, Molecular and Cellular Biology.

[51]  R. Mahadevan,et al.  The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. , 2003, Metabolic engineering.

[52]  D. Leys,et al.  Peroxisome Proliferator-Activated Receptor-α Activation as a Mechanism of Preventive Neuroprotection Induced by Chronic Fenofibrate Treatment , 2003, The Journal of Neuroscience.

[53]  Lothar Siekmann,et al.  IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase. , 2002, Clinical chemistry and laboratory medicine.

[54]  M. Panteghini,et al.  IFCC Primary Reference Procedures for the Measurement of Catalytic Activity Concentrations of Enzymes at 37°C. Part 4. Reference Procedure for the Measurement of Catalytic Concentration of Alanine Aminotransferase , 2002 .

[55]  M. Jaye,et al.  PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway , 2001, Nature Medicine.

[56]  A. Groen,et al.  Mechanisms of Biliary Lipid Secretion and Their Role in Lipid Homeostasis , 2000, Seminars in liver disease.

[57]  B. Robinson,et al.  Glucose transport and metabolism in cultured human skin fibroblasts. , 1983, Biochimica et biophysica acta.

[58]  R. Soloway,et al.  Kinetic analysis of biliary lipid excretion in man and dog. , 1976, The Journal of clinical investigation.